These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18495217)

  • 21. [Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome].
    Engelsen J; Nielsen SM; Thorsen S
    Ugeskr Laeger; 2006 Jan; 168(5):486-7. PubMed ID: 16472441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenothiazine-induced lupus anticoagulant.
    Kaslow KA; Rosse RB; Zeller JA; Nagy MS; Deustch SI
    J Clin Psychiatry; 1992 Mar; 53(3):103-4. PubMed ID: 1548247
    [No Abstract]   [Full Text] [Related]  

  • 24. Testing for new oral anticoagulants with LA-resistant Russells viper venom reagents. An in vitro study.
    Exner T; Ellwood L; Rubie J; Barancewicz A
    Thromb Haemost; 2013 Apr; 109(4):762-5. PubMed ID: 23364321
    [No Abstract]   [Full Text] [Related]  

  • 25. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus.
    Yin ET; Gaston LW
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):88-115. PubMed ID: 16955969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Avoiding errors in the laboratory evaluation of potent lupus anticoagulants.
    Penmetsa GK; Rodgers GM; Smock KJ
    Am J Hematol; 2010 Apr; 85(4):272-4. PubMed ID: 20196174
    [No Abstract]   [Full Text] [Related]  

  • 27. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 28. The tissue thromboplastin inhibition test in the detection of lupus anticoagulants: importance of a correction factor eliminating the influence of fibrinogen level.
    Eschwège V; Seddiki S; Robert A
    Thromb Haemost; 1996 Jul; 76(1):65-8. PubMed ID: 8819253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low plasma factor XII activity in patients with systemic lupus erythematosus and a lupus anticoagulant.
    Matsuda J; Gotoh M
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):255-6. PubMed ID: 9199826
    [No Abstract]   [Full Text] [Related]  

  • 30. Significantly Prolonged Prothrombin Time and Activated Partial Thromboplastin Time with no Bleeding Tendency: A Patient with Lupus Anticoagulant-Hypoprothrombinemia Syndrome Positive for Immunoglobulin M Anti-Phosphatidylserine/Prothrombin complex Antibodies.
    Fei Y; Tang N; Zhang H; Li G; Zhang H; Zhang C
    Semin Thromb Hemost; 2020 Jun; 46(4):507-511. PubMed ID: 31877567
    [No Abstract]   [Full Text] [Related]  

  • 31. [The positive rate of lupus anticoagulant according to the each understanding disease in our hospital].
    Omote M; Yoshida T; Asakura H; Ontachi Y; Hayashi T; Morishita E; Yamazaki M; Fujita S; Nakao S
    Rinsho Byori; 2006 Sep; 54(9):903-9. PubMed ID: 17063871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.
    Brandt JT; Triplett DA; Alving B; Scharrer I
    Thromb Haemost; 1995 Oct; 74(4):1185-90. PubMed ID: 8560433
    [No Abstract]   [Full Text] [Related]  

  • 33. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
    Lawrie AS; Mackie IJ; Purdy G; Machin SJ
    Thromb Haemost; 1999 May; 81(5):758-62. PubMed ID: 10365750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixing studies for abnormal coagulation screen - the current trend.
    Mohammad E; Thachil J
    Clin Chem Lab Med; 2017 Mar; 55(3):e54-e55. PubMed ID: 27522100
    [No Abstract]   [Full Text] [Related]  

  • 35. False negative screening tests for lupus anticoagulants--an unrecognized problem?
    Jacobsen EM; Wisløff F
    Thromb Res; 1996 Jun; 82(5):445-51. PubMed ID: 8771705
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of instruments on lupus anticoagulant testing.
    Exner T; Hohnen-Behrens C; Newman P; Dargan W
    Thromb Haemost; 2000 Feb; 83(2):345-8. PubMed ID: 10739397
    [No Abstract]   [Full Text] [Related]  

  • 37. Prothrombin time and partial thromboplastin time assay considerations.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):253-63. PubMed ID: 19665677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH.
    Moore GW; Van Cott EM; Cutler JA; Mitchell MJ; Adcock DM;
    J Thromb Haemost; 2019 Sep; 17(9):1555-1561. PubMed ID: 31317658
    [No Abstract]   [Full Text] [Related]  

  • 39. Lupus anticoagulant testing and anticoagulation do not mix: quantitation of discrepant results and potential approaches to reduce false positives.
    Chandler JB; Torres R; Rinder HM; Tormey CA
    Br J Haematol; 2014 Dec; 167(5):704-7. PubMed ID: 25041401
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis].
    Martin-Toutain I; Vu T; Azgui Z; Piot MT; Jung M; Ankri A
    Ann Biol Clin (Paris); 2004; 62(4):451-5. PubMed ID: 15297241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.